APA (7th ed.) Citation

R, E., BH, M., Y, W., M, H., LA, F., & DM, B. (2019). Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: Results from ACTIVE. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 30(3), 667. https://doi.org/10.1007/s00198-018-04819-1

Chicago Style (17th ed.) Citation

R, Eastell, Mitlak BH, Wang Y, Hu M, Fitzpatrick LA, and Black DM. "Bone Turnover Markers to Explain Changes in Lumbar Spine BMD with Abaloparatide and Teriparatide: Results from ACTIVE." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 30, no. 3 (2019): 667. https://doi.org/10.1007/s00198-018-04819-1.

MLA (9th ed.) Citation

R, Eastell, et al. "Bone Turnover Markers to Explain Changes in Lumbar Spine BMD with Abaloparatide and Teriparatide: Results from ACTIVE." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 30, no. 3, 2019, p. 667, https://doi.org/10.1007/s00198-018-04819-1.